Arcadia Biosciences, Inc. — Director's Dealing 2015

May 15, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2015-05-12

Reporting Person: Mandala Agribusiness Co-Investments I Ltd (10% Owner)
Reporting Person: Mandala Agribusiness Fund (10% Owner)
Reporting Person: Redfern Dominic (10% Owner)
Reporting Person: Gujadhur Tej (10% Owner)
Reporting Person: Gujadhur Sheokumar (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series D Preferred Stock	$		Common Stock (8918750)		Direct
Warrant (right to buy)	$18.164		Common Stock (668906)		Direct
Warrant (right to buy)	$18.164		Common Stock (408776)		Direct
Warrant (right to buy)	$18.164		Common Stock (37161)		Direct

Footnotes

F1: The Series D Convertible Preferred Stock is convertible into the issuer's common stock at a conversion ratio that is dependent upon the initial public offering price of the issuer's common stock in its initial public offering, and has no exiration date. It will convert into common stock upon the closing of the issuer's initial public offering. The number of underlying shares of common stock reported in Column 3 does not reflect a 1-for-4 reverse stock split effected by the issuer on the date hereof, which will result in a proportional adjustment to the conversion ratio of the Series D Convertible Preferred Stock upon the conversion of the Series D Convertible Preferred Stock into common stock upon the closing of the issuer's initial public offering.

F2: The Series D preferred stock and common stock issuable upon exercise of warrants are held by Mandala Agribusiness Co-Investments I Limited. Dominic Redfern, Tej Gujadhur and Sheokumar Gujadhur are members of the board of Mandala Agribusiness Fund, which exercises shared voting and investment power over the shares owned by Mandala Agribusiness Co-Investments I Limited. Dominic Redfern, Tej Gujadhur and Sheokumar Gujadhur disclaim beneficial ownership of all securities listed herein, except to the extent of their respective pecuniary interests therein.

F3: The Warrant will expire on the later of April 8, 2019 or the second anniversary of the closing of the issuer's initial public offering.

F4: The Warrant will expire on the later of May 5, 2019 or the second anniversary of the closing of the issuer's initial public offering.

F5: The Warrant will expire on the later of May 12, 2019 or the second anniversary of the closing of the issuer's initial public offering.